Carret Asset Management, LLC Gilead Sciences, Inc. Transaction History

Carret Asset Management, LLC

$898 Million
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	SELL	$63.15 - $72.88 $50,520 - $58,304	-800 Reduced 11.36%	6,243 $428,000
Q1 2024 Apr 18, 2024	BUY	$71.58 - $87.29 $50,106 - $61,103	700 Added 11.04%	7,043 $515,000
Q4 2023 Feb 02, 2024	SELL	$73.27 - $83.09 $1,245 - $1,412	-17 Reduced 0.27%	6,343 $513,000
Q3 2023 Oct 12, 2023	SELL	$73.94 - $80.67 $5,545 - $6,050	-75 Reduced 1.17%	6,360 $476,000
Q2 2023 Jul 25, 2023	SELL	$76.01 - $86.7 $26,603 - $30,345	-350 Reduced 5.16%	6,435 $495,000
Q1 2023 May 11, 2023	SELL	$77.31 - $88.08 $19,327 - $22,020	-250 Reduced 3.55%	6,785 $562,000
Q4 2022 Jan 10, 2023	SELL	$62.32 - $89.47 $34,587 - $49,655	-555 Reduced 7.31%	7,035 $604,000
Q3 2022 Oct 11, 2022	SELL	$59.54 - $68.01 $14,885 - $17,002	-250 Reduced 3.19%	7,590 $468,000
Q2 2022 Aug 04, 2022	SELL	$57.72 - $65.01 $17,316 - $19,503	-300 Reduced 3.69%	7,840 $485,000
Q1 2022 Apr 13, 2022	BUY	$57.92 - $72.58 $54,444 - $68,225	940 Added 13.06%	8,140 $484,000
Q3 2021 Oct 27, 2021	SELL	$67.69 - $73.03 $40,614 - $43,818	-600 Reduced 7.69%	7,200 $503,000
Q1 2021 Jul 14, 2021	SELL	$60.0 - $68.46 $7,740 - $8,831	-129 Reduced 1.63%	7,800 $504,000
Q4 2020 Mar 16, 2021	SELL	$56.65 - $64.55 $11,330 - $12,910	-200 Reduced 2.46%	7,929 $462,000
Q3 2020 Nov 16, 2020	BUY	$62.1 - $78.08 $40,365 - $50,752	650 Added 8.69%	8,129 $514,000
Q2 2020 Aug 12, 2020	BUY	$72.34 - $84.0 $72,340 - $84,000	1,000 Added 15.43%	7,479 $575,000
Q1 2020 May 18, 2020	SELL	$62.63 - $80.22 $62,630 - $80,220	-1,000 Reduced 13.37%	6,479 $484,000
Q4 2019 Feb 13, 2020	BUY	$61.62 - $67.78 $26,188 - $28,806	425 Added 6.02%	7,479 $486,000
Q2 2019 Aug 12, 2019	BUY	$61.87 - $69.38 $68,923 - $77,289	1,114 Added 18.75%	7,054 $477,000
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $68,783 - $77,055	1,100 Added 22.73%	5,940 $386,000
Q4 2018 Feb 13, 2019	SELL	$60.54 - $79.0 $108,427 - $141,489	-1,791 Reduced 27.01%	4,840 $303,000
Q2 2018 Aug 08, 2018	BUY	$64.88 - $75.68 $32,439 - $37,840	500 Added 8.16%	6,631 $470,000
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $25,494 - $31,080	-350 Reduced 5.4%	6,131 $462,000
Q4 2017 Feb 13, 2018	SELL	$71.15 - $83.52 $21,345 - $25,056	-300 Reduced 4.42%	6,481 $464,000
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $72,110 - $85,470	1,000 Added 17.3%	6,781 $549,000
Q2 2017 Aug 15, 2017	BUY	N/A	5,781	5,781 $409,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.09 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.72 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.57 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Carret Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carret Asset Management, LLC with notifications on news.

Account